DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 2.610
EU - Europa 1.515
AS - Asia 450
AF - Africa 98
SA - Sud America 10
Totale 4.683
Nazione #
US - Stati Uniti d'America 2.543
IT - Italia 701
CN - Cina 401
IE - Irlanda 147
UA - Ucraina 140
FI - Finlandia 138
NL - Olanda 109
DE - Germania 103
CI - Costa d'Avorio 96
SE - Svezia 69
CA - Canada 66
GB - Regno Unito 55
VN - Vietnam 24
FR - Francia 11
RU - Federazione Russa 10
IS - Islanda 7
BG - Bulgaria 6
BR - Brasile 6
IN - India 6
ES - Italia 5
SG - Singapore 5
HU - Ungheria 4
PK - Pakistan 4
CL - Cile 3
IR - Iran 3
PL - Polonia 3
TR - Turchia 3
BE - Belgio 2
ID - Indonesia 2
NG - Nigeria 2
AT - Austria 1
CH - Svizzera 1
CO - Colombia 1
GR - Grecia 1
JP - Giappone 1
MX - Messico 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
Totale 4.683
Città #
Chandler 443
Millbury 204
Jacksonville 172
Princeton 145
Ashburn 130
Naples 115
Nanjing 114
Beijing 106
Amsterdam 97
Wilmington 88
Norwalk 78
Boston 77
Des Moines 75
Houston 72
Ottawa 57
Napoli 56
Nanchang 45
Woodbridge 41
Rome 38
Lawrence 34
Seattle 33
Shenyang 28
Hebei 27
Dong Ket 24
Jiaxing 23
Falls Church 20
Kronberg 20
Changsha 18
Milan 15
Boardman 12
Dublin 11
Nuremberg 10
Tianjin 10
Kunming 9
Redwood City 9
Cambridge 8
Ortona 8
Aversa 7
Fairfield 7
Portici 7
Reykjavík 7
Cagliari 6
Catania 6
Council Bluffs 6
Monza 6
Paris 6
Turin 6
Brooklyn 5
Concordia Sagittaria 5
Gallipoli 5
Genova 5
Guangzhou 5
Indiana 5
New York 5
Orange 5
Palermo 5
Salerno 5
Tulsa 5
Avellino 4
Lappeenranta 4
Somma Vesuviana 4
Toronto 4
Ann Arbor 3
Caivano 3
Cologne 3
Eindhoven 3
Fisciano 3
Foligno 3
Hangzhou 3
Hanover 3
Padova 3
Pagani 3
Pescara 3
Rawalpindi 3
Southend 3
Teverola 3
Abuja 2
Acerra 2
Angri 2
Arzano 2
Barakaldo 2
Bari 2
Benevento 2
Boscoreale 2
Cankaya 2
Capaccio 2
Castelvecchio Subequo 2
Cutrofiano 2
Duncan 2
Etobicoke 2
Foggia 2
Formia 2
Fort Worth 2
Limoges 2
Liscate 2
Martock 2
Mestre 2
Miller Place 2
Molfetta 2
Moscow 2
Totale 2.697
Nome #
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 67
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 63
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 59
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 55
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 55
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 54
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 52
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 52
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 50
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. 48
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 48
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 47
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment 45
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 45
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 44
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 44
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 44
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 43
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 41
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 40
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 40
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. 39
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 39
A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: A multimodal genetic imaging study 39
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis 39
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. 38
Dopaminergic regulation of epileptic activity. 38
Antypsychotic induced gene expression in the rat brain: a computational and experimental approach 37
L'Araba Fenice delle psicosi: rinascita e trasformazione dell'ipotesi dopaminergica 37
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 37
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 37
Acute administration of antipsychotics modulates Homer striatal gene expression differentially. 36
Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. 36
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 36
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 36
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 36
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 36
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. 35
Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia 35
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 35
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 35
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. 34
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 34
Meccanismi convergenti e divergenti nel dolore e nella depressione 33
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 33
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 33
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 33
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. 32
Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies. 32
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 32
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice. 31
Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse 31
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 31
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 31
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 31
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 31
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 31
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 31
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 31
Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study 30
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. 30
Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg). 30
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 30
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 30
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 30
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 30
The Psychiatric Neuromodulation Unit: Implementation and Management 30
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 30
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 30
Disturbo da uso di alcol 29
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 29
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 29
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain 28
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 28
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 28
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 28
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 28
Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis 27
Fisiopatologia cellulare e molecolare 27
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 27
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 27
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. 26
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 26
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 26
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 26
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 25
Neurobiological correlates of anxiety treatment.(Le basi neurobiologiche della terapia dell’ansia) 25
Augmentation therapy of antipsychotics by no conventional drugs in schizophrenia treatment 25
Dandy-Walker Syndrome with psychotic symptoms: A case report 25
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 25
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 25
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 24
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 24
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 24
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 24
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 24
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 24
Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia 23
Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. 23
Clinical predictors of acute response to transcranial direct current stimulation (tDCS) in major depression 23
Totale 3.449
Categoria #
all - tutte 21.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 21 5
2019/2020647 236 57 31 18 56 18 12 5 4 63 86 61
2020/2021515 35 30 60 42 43 97 44 3 76 21 36 28
2021/2022971 14 1 8 11 8 48 22 32 162 79 163 423
2022/20231.187 193 95 35 49 138 160 14 108 159 103 89 44
2023/2024757 33 146 92 92 59 51 60 161 35 26 2 0
Totale 5.006